17.04.2019 19:30:02

DGAP-News: Mid Stabilisation Notice - Medacta Group SA

DGAP-News: Credit Suisse Securities (Europe) Limited / Key word(s): Miscellaneous
Mid Stabilisation Notice - Medacta Group SA

17.04.2019 / 19:30
The issuer is solely responsible for the content of this announcement.


17/04/2019

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.
Medacta Group SA

Mid-stabilisation Period Announcement


Credit Suisse Securities (Europe) Limited (contact: Lloyd Adams; +44 (0) 207 888 6341) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities within the limitations of Article 126 of the Swiss Ordinance on Financial Market Infrastructures and Market Conduct in Securities and Derivatives Trading (FMIO).
Securities

Issuer: Medacta Group SA
Guarantor (if any): N/A
Aggregate nominal amount: 855,000 Registered Shares
Description: Registered Shares
Stabilisation Manager(s): Credit Suisse Securities (Europe) Limited

(Acting on behalf of Credit Suisse AG)
 


Stabilisation transaction[s]

Date Price Limit (CHF) Units Bought
11/04/2019 96.00 50,000
11/04/2019 95.60 50,000
11/04/2019 95.45 50,000
12/04/2019 95.20 32,500
15/04/2019 95.15 15,500
16/04/2019 95.15 4,797
16/04/2019 95.27 10,000
17/04/2019 95.15 30,000
17/04/2019 95.00 30,000
17/04/2019 94.50 30,000
17/04/2019 94.00 30,000
17/04/2019 93.50 13,057
 

 

Stabilisation trading venue SIX - SWISS EXCHANGE
 



This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.



17.04.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Credit Suisse Securities (Europe) Limited
Taunustor 1
60310 Frankfurt
Germany
Phone: +49 69 75380
E-mail: info@credit-suisse.com
Internet: www.credit-suisse.com
ISIN: CH0468525222
Listed: Regulated Market in Frankfurt (Prime Standard)
EQS News ID: 801447

 
End of News DGAP News Service

801447  17.04.2019 

fncls.ssp?fn=show_t_gif&application_id=801447&application_name=news&site_id=smarthouse

Analysen zu Medactamehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Medacta 78,60 2,12% Medacta